Skip to content

Effectiveness study of steroid in severe community acquired pneumonia

Short course Dexamethasone therapy in under 5 children with acute severe community acquired pneumonia requiring oxygen therapy admitted to PICUââ?¬â?? a parallel arm double blinded randomised controlled trial. - Dexa-CAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040039
Enrollment
40
Registered
2022-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J189- Pneumonia, unspecified organism

Interventions

Intervention1: intravenous steroid- Inj Dexamethasone: Inj Dexamethasone day 1- 0.6 mg/kg , day2 -0.6 mg/kg day3 -0.3 mg/kg day4 -0.15 mg/kg Control Intervention1: Standard care: No dexamethasone ,

Sponsors

Dr Mehta Childrens hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive children aged 1month to 60 months admitted to PICU with ââ?¬Å?severe pneumonia requiring oxygen therapyââ?¬? would be enrolled in this study after getting informed consent from parents.

Exclusion criteria

Exclusion criteria: 1.Children diagnosed to have chronic lung disease 2.Any child hospitalized for respiratory illness in last one month period 3.Children previously diagnosed to have bronchial asthma 4.Children receiving home mechanical ventilation 5.Children diagnosed to have preexisting neuromuscular disease 6.Children diagnosed to have pre existing adrenal insufficiency 7.Children diagnosed to have empyema at admission to emergency room 8.Children diagnosed to have pre existing immunocompromised conditions 9.Children diagnosed to have Tuberculosis before admission

Design outcomes

Secondary

MeasureTime frame
Rise in secondary infections , Complications like - hyperglycemia , Gastrointestinal bleeding , hypertension .Timepoint: Till the time child is admitted in PICU

Primary

MeasureTime frame
The primary outcome parameter in patients after randomisation to steroid and placebo group is the duration of oxygen therapy ( in hours) during the first 5 days of admissionTimepoint: The primary outcome parameter in patients after randomisation to steroid and placebo group is the duration of oxygen therapy ( in hours) during the first 5 days of admission

Countries

India

Contacts

Public ContactAiswarya Sankar

Dr Mehta Childrens Hospital

sasidarpgi@gmail.com9677275167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026